|
APPBP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.84879999484988E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.017600E-03 |
| Normal-vs-Stage2 |
1.703480E-03 |
| Normal-vs-Stage3 |
5.85170023548187E-10 |
| Normal-vs-Stage4 |
4.81380046934987E-10 |
| Stage1-vs-Stage2 |
9.652500E-02 |
| Stage1-vs-Stage3 |
7.74430000000104E-05 |
| Stage1-vs-Stage4 |
2.4198999999947E-05 |
| Stage2-vs-Stage3 |
3.335400E-01 |
| Stage2-vs-Stage4 |
1.521620E-01 |
| Stage3-vs-Stage4 |
4.557000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.38809999447898E-08 |
| Normal-vs-AfricanAmerican |
2.200700E-03 |
| Normal-vs-Asian |
8.135000E-01 |
| Caucasian-vs-AfricanAmerican |
9.433000E-01 |
| Caucasian-vs-Asian |
1.805160E-01 |
| AfricanAmerican-vs-Asian |
2.629400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.49459999931878E-09 |
| Normal-vs-Female |
1.281630E-03 |
| Male-vs-Female |
4.101800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.606700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.226210E-04 |
| Normal-vs-Age(61-80Yrs) |
5.31550004012615E-09 |
| Normal-vs-Age(81-100Yrs) |
4.357900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.657800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.541600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.588400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.572400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.071000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.144400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.547000E-01 |
| Normal-vs-Grade 2 |
2.323800E-03 |
| Normal-vs-Grade 3 |
9.45800004981123E-09 |
| Normal-vs-Grade 4 |
1.677880057116E-12 |
| Grade 1-vs-Grade 2 |
1.168770E-01 |
| Grade 1-vs-Grade 3 |
4.139400E-03 |
| Grade 1-vs-Grade 4 |
1.94559999999733E-06 |
| Grade 2-vs-Grade 3 |
3.405000E-03 |
| Grade 2-vs-Grade 4 |
2.29290000319793E-08 |
| Grade 3-vs-Grade 4 |
1.716610E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.570440E-02 |
| Normal-vs-ccB subtype |
3.85590000040459E-07 |
| ccA subtype-vs-ccB subtype |
1.499240E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.60044999999442E-05 |
| Normal-vs-N1 |
5.625400E-04 |
| N0-vs-N1 |
3.144800E-01 |
|
|
